デフォルト表紙
市場調査レポート
商品コード
1726190

頭蓋内動脈瘤の市場規模、シェア、動向分析レポート:タイプ別、最終用途別、地域別、セグメント予測、2025年~2030年

Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type, (Surgical Clipping, Endovascular Coiling, Flow Diverters), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 110 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
頭蓋内動脈瘤の市場規模、シェア、動向分析レポート:タイプ別、最終用途別、地域別、セグメント予測、2025年~2030年
出版日: 2025年04月09日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

頭蓋内動脈瘤市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の頭蓋内動脈瘤市場規模は2030年に27億4,000万米ドルに達すると予測され、2025~2030年にかけてCAGR 9.9%で成長すると予測されています。

同市場の成長は、脳卒中症例の増加、脳血管障害を患う人々の発生率の増加、主要企業による継続的な製品発売など、様々な要因に起因しています。さらに、可処分所得水準が拡大し、医療へのアクセスが改善された市場でも急速に成長しています。現在、脳動脈瘤の原因は明確に解明されていないです。しかし、加齢、脳外傷、遺伝性、高血圧、動脈硬化、感染症、座りっぱなしのライフスタイルなど、この症状に関連するさまざまな要因があります。注目すべき症状は、脳神経の機能障害、局所的な頭痛、複視などがあります。

その結果、頭蓋内動脈瘤に罹患する人口の増加が市場の拡大に寄与しています。このセグメントの企業は、既存の治療法をより安全で効果的なものにすると同時に、新しい技術を導入する方法を常に模索しており、これが頭蓋内動脈瘤製品に対する需要を世界的に増加させると予想されます。例えば、2022年6月には、India MedtronicがCEマークを取得した第4世代のフローディフレクタ「パイプラインバンテージ・ウィズ・シールド技術」が脳動脈瘤の血管内治療用に開発されました。新たに開発されたフローディフレクタ「パイプラインバンテージ」は、シールド技術を搭載し、デリバリーシステムとインプラントの両方の設計の特徴を強化しています。標的血管の最内層で細胞の発達を促進する骨格を開発することで、医師が脳動脈瘤や頭蓋内動脈瘤を送達、展開、修復することをより容易かつ確実にします。

頭蓋内動脈瘤市場レポートハイライト

  • 世界市場では、血管内治療機器と送達システムの両方において革新が進み、かなりの程度の技術革新が見られました。
  • 血管内コイリング部門が2024年に72.4%の最大売上シェアで市場を牽引。血管内コイリング技術は、脳内の動脈瘤を特定し治療するためにカテーテルを用いる低侵襲的な手技です。
  • フローダイバータセグメントは、予測期間中最も速いCAGR 13.4%で成長する見込みです。フローダイバータ技術の絶え間ない進化が市場成長を後押ししています。
  • 病院セグメントは世界の頭蓋内動脈瘤市場を独占し、2024年には88.9%の最大の収益シェアを占めました。
  • 北米の頭蓋内動脈瘤市場は、確立された医療インフラの存在、高齢者の増加、高血圧と脳卒中の高い発生率により、世界市場を独占し、2024年に27.6%の最大の収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の頭蓋内動脈瘤市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 世界の頭蓋内動脈瘤市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 世界の頭蓋内動脈瘤市場:タイプ別ビジネス分析

  • タイプセグメントダッシュボード
  • 頭蓋内動脈瘤市場:タイプ変動分析
  • 世界の頭蓋内動脈瘤市場規模と動向分析(タイプ別、2018~2030年)
  • 外科的クリッピング
  • 血管内コイル塞栓術

第5章 世界の頭蓋内動脈瘤市場:最終用途別ビジネス分析

  • 最終用途セグメントダッシュボード
  • 頭蓋内動脈瘤市場:最終用途変動分析
  • 世界の頭蓋内動脈瘤市場規模と動向分析(最終用途別、2018~2030年)
  • 病院
  • クリニック
  • その他

第6章 世界の頭蓋内動脈瘤市場:地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 地域別市場シェア分析、2024年と2030年
  • 地域の頭蓋内動脈瘤市場:主要ポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • Key Company ヒートマップ分析、2024年
  • 企業プロファイル
    • Medtronic plc
    • Stryker Corporation
    • MicroPort Scientific Corporation
    • Johnson & Johnson Services, Inc.
    • MicroVention Inc.
    • B. Braun Melsungen AG
    • Integra LifeSciences
    • RAUMEDIC AG
    • Terumo Corporation
    • Delta Surgical
図表

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 3 Global Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 4 Global Intracranial Aneurysm Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 North America Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 U.S Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10 Canada Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Mexico Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14 Europe Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Europe Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 17 Germany Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Germany Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 UK Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 France Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 France Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23 Italy Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Italy Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Spain Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Spain Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 27 Denmark Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Denmark Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 Sweden Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 Sweden Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 Norway Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Norway Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 China Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 37 China Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 Japan Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Japan Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 India Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 India Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42 South Korea Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 South Korea Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Australia Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Australia Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Thailand Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Thailand Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Latin America Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Latin America Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Latin America Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 Latin America Intracranial Aneurysm Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Brazil Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 53 Brazil Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Argentina Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 MEA Intracranial Aneurysm Market, By Region, 2018 - 2030 (USD Million)
  • Table 57 MEA Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 MEA Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 South Africa Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63 UAE Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 UAE Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Intracranial Aneurysm Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Intracranial Aneurysm Market: Market Outlook
  • Fig. 10 Intracranial Aneurysm Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Intracranial Aneurysm Market Driver Impact
  • Fig. 16 Intracranial Aneurysm Market Restraint Impact
  • Fig. 17 Intracranial Aneurysm Market Strategic Initiatives Analysis
  • Fig. 18 Intracranial Aneurysm Market: Type Movement Analysis
  • Fig. 19 Intracranial Aneurysm Market: Type Outlook and Key Takeaways
  • Fig. 20 Surgical Clipping Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Endovascular Coiling Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Flow Diverters Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 24 Intracranial Aneurysm Market: End Use Movement Analysis
  • Fig. 25 Intracranial Aneurysm Market: End Use Outlook and Key Takeaways
  • Fig. 26 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 27 Clinics Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 29 Global Intracranial Aneurysm Market: Regional Movement Analysis
  • Fig. 30 Global Intracranial Aneurysm Market: Regional Outlook and Key Takeaways
  • Fig. 31 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Kuwait Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: GVR-4-68038-416-1

Intracranial Aneurysm Market Growth & Trends:

The global intracranial aneurysm market size is anticipated to reach USD 2.74 billion in 2030 and is projected to grow at a CAGR of 9.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

Intracranial Aneurysm Market Report Highlights:

  • The global market has experienced a significant degree of innovation, with innovations in both endovascular devices and delivery systems.
  • The endovascular coiling segment led the market with the largest revenue share of 72.4% in 2024. The endovascular coiling technique is a minimally invasive procedure that employs a catheter to identify and treat aneurysms in the brain.
  • The flow diverters segment is expected to grow at the fastest CAGR of 13.4% over the forecast period. The continuous evolution of flow diverter technology boosts the market growth.
  • The hospital segment dominated the global intracranial aneurysm market and accounted for the largest revenue share of 88.9% in 2024.
  • North America intracranial aneurysm market dominated the global market and accounted for the largest revenue share of 27.6% in 2024 owing to the presence of well-established healthcare infrastructure, the rising geriatric population, and the high incidence of hypertension and stroke.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Intracranial Aneurysm Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Intracranial Aneurysm Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Intracranial Aneurysm Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Intracranial Aneurysm Market: Type Movement Analysis
  • 4.3. Global Intracranial Aneurysm Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. Surgical Clipping
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Endovascular Coiling
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Intracranial Aneurysm Market: End Use Business Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Intracranial Aneurysm Market: End Use Movement Analysis
  • 5.3. Global Intracranial Aneurysm Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Clinics
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Intracranial Aneurysm Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Global Intracranial Aneurysm Market by Regional: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Germany
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.1.3. Competitive Scenario
      • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Thailand
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. South Africa
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.3.3. Competitive Scenario
      • 6.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.4.3. Competitive Scenario
      • 6.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Medtronic plc
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Stryker Corporation
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. MicroPort Scientific Corporation.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Johnson & Johnson Services, Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. MicroVention Inc.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. B. Braun Melsungen AG
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Integra LifeSciences
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. RAUMEDIC AG
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiative
    • 7.4.9. Terumo Corporation
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Delta Surgical
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives